Back to URGN
Aisling Capital Management LP → URGN
Aisling Capital Management LP URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
4
Latest value
$4.4M
Q3 2026
Peak value
$4.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.5M |
| Q1 2026 | $1.9M |
| Q2 2026 | $4M |
| Q3 2026 | $4.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.4M | 108.0K | — | — |
| Q2 2026 | $4M | 108.0K | — | — |
| Q1 2026 | $1.9M | 108.0K | — | — |
| Q4 2025 | $2.5M | 108.0K | — | — |
Other funds holding URGN
$184.6M
$167.2M
$106.4M
$93.6M
$91.7M
Other Aisling Capital Management LP positions
BBIO
$389.3MBridgeBio Pharma Inc. (BBIO)
BBIO
$378MBridgeBio Pharma Inc. (BBIO)
BBIO
$341.8MBRIDGEBIO PHARMA INC
BBIO
$203.3MBRIDGEBIO PHARMA INC
MNST
$37.6MMONTE ROSA THERAPEUTICS INC
SNDX
$30.8MSyndax Pharmaceuticals, Inc. (SNDX)
SNDX
$28.8MSYNDAX PHARMACEUTICALS INC
SNDX
$27.7MSyndax Pharmaceuticals, Inc. (SNDX)